Search Results - Capoulade‐Metay, C

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    The contribution of germline rearrangements to the spectrum of BRCA2 mutations

    The contribution of germline rearrangements to the spectrum of BRCA2 mutations by Casilli, F, Tournier, I, Sinilnikova, O M, Coulet, F, Soubrier, F, Houdayer, C, Hardouin, A, Berthet, P, Sobol, H, Bourdon, V, Muller, D, Fricker, J P, Capoulade-Metay, C, Chompret, A, Nogues, C, Mazoyer, S, Chappuis, P, Maillet, P, Philippe, C, Lortholary, A, Gesta, P, Bézieau, S, Toulas, C, Gladieff, L, Maugard, C M, Provencher, D M, Dugast, C, Delvincourt, C, Nguyen, T D, Faivre, L, Bonadona, V, Frébourg, T, Lidereau, R, Stoppa-Lyonnet, D, Tosi, M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Is long‐term virological response related to CCR5 Δ32 deletion in HIV‐1‐infected patients started on highly active antiretroviral therapy?

    Is long‐term virological response related to CCR5 Δ32 deletion in HIV‐1‐infected patients started on highly active antiretroviral therapy? by Laurichesse, J‐J, Taieb, A, Capoulade‐Metay, C, Katlama, C, Villes, V, Drobacheff‐Thiebaud, M‐C, Raffi, F, Chêne, G, Theodorou, I, Leport, C

    Published in HIV medicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Is long-term virological response related to CCR5 32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?

    Is long-term virological response related to CCR5 32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? by Laurichesse, J-J, Taieb, A, Capoulade-Metay, C, Katlama, C, Villes, V, Drobacheff-Thiebaud, M-C, Raffi, F, Chene, G, Theodorou, I, Leport, C

    Published in HIV medicine
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?

    Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? by Laurichesse, J-J, Taieb, A, Capoulade-Metay, C, Katlama, C, Villes, V, Drobacheff-Thiebaud, M-C, Raffi, F, Chêne, G, Theodorou, I, Leport, C

    Published in HIV medicine
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia

    32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia by Kamkamidze, G, Capoulade-Metay, C, Butsashvili, M, Dudoit, Y, Chubinishvili, O, Debre, P, Theodorou, L

    Published in Georgian medical news
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: